Kronos Bio Analyst Ratings
Kronos Bio Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/27/2023 | 650% | HC Wainwright & Co. | → $9 | Reiterates | Buy → Buy |
| 08/21/2023 | 650% | HC Wainwright & Co. | $10 → $9 | Maintains | Buy |
| 04/17/2023 | 733.33% | HC Wainwright & Co. | → $10 | Reiterates | → Buy |
| 11/18/2022 | 733.33% | HC Wainwright & Co. | $36 → $10 | Maintains | Buy |
| 11/10/2022 | 1066.67% | Goldman Sachs | $25 → $14 | Maintains | Buy |
| 11/09/2022 | 483.33% | Piper Sandler | $13 → $7 | Maintains | Overweight |
| 09/14/2022 | 900% | Berenberg | → $12 | Initiates Coverage On | → Buy |
| 05/24/2022 | 1816.67% | Goldman Sachs | $35 → $23 | Maintains | Buy |
| 05/23/2022 | 983.33% | Piper Sandler | $30 → $13 | Maintains | Overweight |
| 02/28/2022 | 2400% | Piper Sandler | $50 → $30 | Maintains | Overweight |
| 11/10/2021 | 2900% | HC Wainwright & Co. | $35 → $36 | Maintains | Buy |
| 06/24/2021 | 2816.67% | HC Wainwright & Co. | → $35 | Initiates Coverage On | → Buy |
| 11/03/2020 | — | Cowen & Co. | Initiates Coverage On | → Outperform | |
| 11/03/2020 | 3650% | Goldman Sachs | → $45 | Initiates Coverage On | → Buy |
| 11/03/2020 | 4066.67% | Piper Sandler | → $50 | Initiates Coverage On | → Overweight |
| 日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 11/27/2023 | 650% | HC Wainwright & Co. | → 9 美元 | 重申 | 購買 → 購買 |
| 08/21/2023 | 650% | HC Wainwright & Co. | 10 美元 → 9 美元 | 維護 | 買 |
| 04/17/2023 | 733.33% | HC Wainwright & Co. | → 10 美元 | 重申 | → 購買 |
| 11/18/2022 | 733.33% | HC Wainwright & Co. | 36 美元 → 10 美元 | 維護 | 買 |
| 2022 年 10 月 11 日 | 1066.67% | 高盛 | 25 美元 → 14 美元 | 維護 | 買 |
| 11/09/2022 | 483.33% | 派珀·桑德勒 | 13 美元 → 7 美元 | 維護 | 超重 |
| 09/14/2022 | 900% | 貝倫貝格 | → 12 美元 | 啓動覆蓋範圍開啓 | → 購買 |
| 2022 年 5 月 24 日 | 1816.67% | 高盛 | 35 美元 → 23 美元 | 維護 | 買 |
| 05/23/2022 | 983.33% | 派珀·桑德勒 | 30 美元 → 13 美元 | 維護 | 超重 |
| 02/28/2022 | 2400% | 派珀·桑德勒 | 50 美元 → 30 美元 | 維護 | 超重 |
| 11/10/2021 | 2900% | HC Wainwright & Co. | 35 美元 → 36 美元 | 維護 | 買 |
| 2021 年 6 月 24 日 | 2816.67% | HC Wainwright & Co. | → 35 美元 | 啓動覆蓋範圍開啓 | → 購買 |
| 11/03/2020 | — | Cowen & Co. | 啓動覆蓋範圍開啓 | → 跑贏大盤 | |
| 11/03/2020 | 3650% | 高盛 | → 45 美元 | 啓動覆蓋範圍開啓 | → 購買 |
| 11/03/2020 | 4066.67% | 派珀·桑德勒 | → 50 美元 | 啓動覆蓋範圍開啓 | → 超重 |
What is the target price for Kronos Bio (KRON)?
克羅諾斯生物（KRON）的目標價格是多少？
The latest price target for Kronos Bio (NASDAQ: KRON) was reported by HC Wainwright & Co. on November 27, 2023. The analyst firm set a price target for $9.00 expecting KRON to rise to within 12 months (a possible 650.00% upside). 3 analyst firms have reported ratings in the last year.
HC Wainwright & Co. 於2023年11月27日公佈了克羅諾斯生物（納斯達克股票代碼：KRON）的最新目標股價。該分析公司將目標股價定爲9.00美元，預計KRON將在12個月內升至12個月內（可能上漲650.00％）。去年有3家分析公司公佈了評級。
What is the most recent analyst rating for Kronos Bio (KRON)?
Kronos Bio（KRON）的最新分析師評級是多少？
The latest analyst rating for Kronos Bio (NASDAQ: KRON) was provided by HC Wainwright & Co., and Kronos Bio reiterated their buy rating.
HC Wainwright & Co. 提供了克羅諾斯生物（納斯達克股票代碼：KRON）的最新分析師評級，克羅諾斯生物重申了其買入評級。
When is the next analyst rating going to be posted or updated for Kronos Bio (KRON)?
Kronos Bio（KRON）的下一次分析師評級何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Kronos Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Kronos Bio was filed on November 27, 2023 so you should expect the next rating to be made available sometime around November 27, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括瀏覽公開財務報表，與Kronos Bio的高管和客戶交談，以及聽取業績電話會議。大多數分析師每三個月做一次這樣的評級，因此每家公司每年應該獲得4次評級。Kronos Bio的最新評級是在2023年11月27日發佈的，因此您應該預計下一個評級將在2024年11月27日左右公佈。
Is the Analyst Rating Kronos Bio (KRON) correct?
分析師對克羅諾斯生物（KRON）的評級是否正確？
While ratings are subjective and will change, the latest Kronos Bio (KRON) rating was a reiterated with a price target of $0.00 to $9.00. The current price Kronos Bio (KRON) is trading at is $1.20, which is within the analyst's predicted range.
儘管評級是主觀的，並且會發生變化，但重申了最新的克羅諾斯生物（KRON）評級，目標股價爲0.00美元至9.00美元。克羅諾斯生物（KRON）目前的交易價格爲1.20美元，在分析師的預測區間內。
譯文內容由第三人軟體翻譯。